Thank you to all that attended! To watch again, click HERE.
Modernizing Eligibility Criteria in Clinical Trials: How We Can Improve Patient Access and Representation
An ASCO-Friends Virtual Meeting
Friday, April 9, 2021
1:00PM EDT – 2:00PM EDT
Opening Keynote Conversation Featuring:
Ed Kim, Physician-in-Chief, City of Hope (Moderator)
Ned Sharpless, Director, National Cancer Institute
Janet Woodcock, Acting Commissioner, U.S. FDA
The American Society of Clinical Oncology (ASCO) and Friends of Cancer Research (Friends) are proud to announce a new virtual meeting building on our work to broaden eligibility criteria to make clinical trials more representative. The ASCO-Friends Virtual Meeting, Modernizing Eligibility Criteria in Clinical Trials: How We Can Improve Patient Access and Representation, will bring together experts from across the healthcare sector to discuss the most recent release of the new ASCO-Friends recommendations for modernizing eligibility criteria. Keynotes and panels will discuss how overly restrictive eligibility criteria can impact patient access to trials, trial accrual rates, and limit the ability to generalize the results to the broader population of patients who will ultimately use the drug.
The final agenda is included below. For more information on the project, click HERE and register above.
Final Agenda
1:00PM: Welcome and Opening Remarks
- Lori Pierce, President, American Society of Clinical Oncology
- Ellen Sigal, Founder and Chair, Friends of Cancer Research
1:05PM: Opening Keynote
- Ed Kim, Physician-in-Chief, City of Hope (Moderator)
- Ned Sharpless, Director, National Cancer Institute
- Janet Woodcock, Acting Commissioner, U.S. Food and Drug Administration
1:20PM: Impact Analysis Presentation
- R. Donald Harvey, Winship Cancer Institute, Emory University School of Medicine
1:30PM: Panel Discussion
- Tom Uldrick, Fred Hutchinson Cancer Research Center (Moderator)
- Julia Beaver, U.S. Food and Drug Administration
- Ray Perez, Bristol Myers Squibb
- Patty Spears, Patient Advocate
Closing
- Jeff Allen, President & CEO, Friends of Cancer Research
